Literature DB >> 31564465

Lithium: past, present, and future.

David A Cousins1, Letizia Squarcina2, Fawzi Boumezbeur3, Allan H Young4, Frank Bellivier5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31564465     DOI： 10.1016/S2215-0366(19)30365-7

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  3 in total

1.  Lithium Ascorbate as a Promising Neuroprotector: Fundamental and Experimental Studies of an Organic Lithium Salt.

Authors:  Ivan Yu Torshin; Olga A Gromova; Konstantin S Ostrenko; Marina V Filimonova; Irina V Gogoleva; Vladimir I Demidov; Alla G Kalacheva
Journal:  Molecules       Date:  2022-03-30       Impact factor: 4.411

2.  A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.

Authors:  Ann L Sharpley; Clare Williams; Adele A Holder; Beata R Godlewska; Nisha Singh; Milensu Shanyinde; Orla MacDonald; Philip J Cowen
Journal:  Psychopharmacology (Berl)       Date:  2020-09-09       Impact factor: 4.530

Review 3.  Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.

Authors:  Enrique L M Ochoa
Journal:  Cell Mol Neurobiol       Date:  2021-08-06       Impact factor: 5.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.